These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 27550940

  • 1. Identification of Pharmacodynamic Transcript Biomarkers in Response to FGFR Inhibition by AZD4547.
    Delpuech O, Rooney C, Mooney L, Baker D, Shaw R, Dymond M, Wang D, Zhang P, Cross S, Veldman-Jones M, Wilson J, Davies BR, Dry JR, Kilgour E, Smith PD.
    Mol Cancer Ther; 2016 Nov; 15(11):2802-2813. PubMed ID: 27550940
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas.
    Fisher MM, SenthilKumar G, Hu R, Goldstein S, Ong IM, Miller MC, Brennan SR, Kaushik S, Abel L, Nickel KP, Iyer G, Harari PM, Kimple RJ, Baschnagel AM.
    Int J Radiat Oncol Biol Phys; 2020 Jul 15; 107(4):793-803. PubMed ID: 32298810
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM, Farooqui M, Rothenberger NJ, Dacic S, Stabile LP.
    Oncotarget; 2017 Apr 11; 8(15):24063-24076. PubMed ID: 28445992
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanisms of Efficacy of the FGFR1-3 Inhibitor AZD4547 in Pediatric Solid Tumor Models.
    Phanhthilath N, Hakim S, Su C, Liu A, Subramonian D, Lesperance J, Zage PE.
    Invest New Drugs; 2020 Dec 11; 38(6):1677-1686. PubMed ID: 32436058
    [Abstract] [Full Text] [Related]

  • 11. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.
    Feng S, Shao L, Castro P, Coleman I, Nelson PS, Smith PD, Davies BR, Ittmann M.
    Oncotarget; 2017 Jan 24; 8(4):6179-6192. PubMed ID: 28008155
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma.
    Le T, New J, Jones JW, Usman S, Yalamanchali S, Tawfik O, Hoover L, Bruegger DE, Thomas SM.
    Int Forum Allergy Rhinol; 2017 Oct 24; 7(10):973-979. PubMed ID: 28707818
    [Abstract] [Full Text] [Related]

  • 15. Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer.
    Shan L, Liu W, Zhan Y.
    Aging (Albany NY); 2019 Sep 23; 11(18):7780-7795. PubMed ID: 31545294
    [Abstract] [Full Text] [Related]

  • 16. Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.
    Sootome H, Fujita H, Ito K, Ochiiwa H, Fujioka Y, Ito K, Miura A, Sagara T, Ito S, Ohsawa H, Otsuki S, Funabashi K, Yashiro M, Matsuo K, Yonekura K, Hirai H.
    Cancer Res; 2020 Nov 15; 80(22):4986-4997. PubMed ID: 32973082
    [Abstract] [Full Text] [Related]

  • 17. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
    Hegab AE, Ozaki M, Kameyama N, Gao J, Kagawa S, Yasuda H, Soejima K, Yin Y, Guzy RD, Nakamura Y, Ornitz DM, Betsuyaku T.
    J Pathol; 2019 Oct 15; 249(2):193-205. PubMed ID: 31090071
    [Abstract] [Full Text] [Related]

  • 18. Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma.
    Maehara O, Suda G, Natsuizaka M, Ohnishi S, Komatsu Y, Sato F, Nakai M, Sho T, Morikawa K, Ogawa K, Shimazaki T, Kimura M, Asano A, Fujimoto Y, Ohashi S, Kagawa S, Kinugasa H, Naganuma S, Whelan KA, Nakagawa H, Nakagawa K, Takeda H, Sakamoto N.
    Carcinogenesis; 2017 Oct 26; 38(11):1073-1083. PubMed ID: 28927233
    [Abstract] [Full Text] [Related]

  • 19. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
    Khandelwal AR, Kent B, Hillary S, Alam MM, Ma X, Gu X, DiGiovanni J, Nathan CO.
    Mol Carcinog; 2019 Oct 26; 58(10):1715-1725. PubMed ID: 31254372
    [Abstract] [Full Text] [Related]

  • 20. FGFR Inhibition Enhances Sensitivity to Radiation in Non-Small Cell Lung Cancer.
    SenthilKumar G, Fisher MM, Skiba JH, Miller MC, Brennan SR, Kaushik S, Bradley ST, Longhurst CA, Buehler D, Nickel KP, Iyer G, Kimple RJ, Baschnagel AM.
    Mol Cancer Ther; 2020 Jun 26; 19(6):1255-1265. PubMed ID: 32371583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.